China · Series A startup

Who invested in Hui-Gene

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$14Mraised across 1 round since 2019, from 1 source

Latest round
Series A, $14MDec 2019
Investors
1
See who backed them

The rounds

  1. Dec 2019
    Series A$14M

    Reported by DealStreetAsia

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Quick answers about Hui-Gene

Who invested in Hui-Gene?

Hui-Gene's investors include CDC Capital Partners.

How much has Hui-Gene raised?

Hui-Gene has raised $14M across 1 round since 2019.

When did Hui-Gene last raise?

Hui-Gene's most recent round was a Series A of $14M in Dec 2019.

What was Hui-Gene's biggest round?

Its most recent round, $14M in Dec 2019, is also its largest on record.

Who backed Hui-Gene first?

Hui-Gene's first round on record, in Dec 2019, was backed by CDC Capital Partners.

What stage is Hui-Gene at?

Hui-Gene's latest named round is a Series A, in Dec 2019.

Where is Hui-Gene based?

Hui-Gene is based in China.

Companies like Hui-Gene

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.